Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Report Overview
The North America chronic inflammatory demyelinating polyneuropathy therapeutics market was valued at USD 775.83 Million in 2025 and is expected to grow at a CAGR of 6.60%, reaching USD 1470.07 Million by 2035. The market is experiencing growth due to increasing diagnostic rates and adoption of novel therapeutics in the region.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
Pharmaceutical companies in North America are actively investing in the research and development of new treatments for CIDP, resulting in increased market growth.
-
The rise in approvals of novel therapies by health regulatory authorities such as the FDA is one of the major market trends.
-
The market share is influenced by the rising advancements in personalized medicine and the growing demand for targeted therapies.
Leading Companies in the North America Chronic Inflammatory Demyelinating Polyneuropathy Therapeutics Market
The key features of the market report include funding and investment analysis, and partnerships and collaborations analysis by the leading key players. The major companies in the market are as follows:
CSL Behring
This United States-based biopharmaceutical company, specializing in manufacturing plasma-derived and recombination therapeutic products, is known for its liquid IgG product Hizentra indicated for the treatment of chronic inflammatory demyelinating polyneuropathy.
Grifols, S.A.
Grifols, S.A., a multinational pharmaceutical and chemical manufacturer, is a leading provider of blood plasma-based products. The company sells its intravenous immunoglobulin (IVIG) under the brands Flebogamma® and Gamunex® for chronic inflammatory demyelinating polyneuropathy (CIDP) patients in the United States and Canada.
Shire
Shire plc, a UK-founded Jersey-registered specialty biopharmaceutical company, is focused on developing treatments for rare diseases. In 2019, it was acquired by Takeda Pharmaceuticals.
Octapharma AG
This Switzerland-based pharmaceutical company is one of the largest providers of high-quality human proteins from human plasma and human cell lines. It has a robust immunoglobulin product portfolio for patients requiring IgG immunotherapy.
Other players in the market include Biogen Idec, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Sanofi, and Roche Holding AG.
North America Chronic Inflammatory Demyelinating Polyneuropathy Therapeutics Market Report Snapshots
North America Chronic Inflammatory Demyelinating Polyneuropathy Therapeutics Market
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The North America chronic inflammatory demyelinating polyneuropathy therapeutics market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 6.60% during the forecast period of 2026-2035.
The rising advancements in personalized medicine and heightened patient awareness are fuelling the demand for the market.
One of the significant trends in the market is the rise in approvals of novel therapeutics by health regulatory authorities. In January 2024, Takeda Pharmaceuticals received FDA approval for its subcutaneous immunoglobin (SCIG) infusion HYQVIA as maintenance therapy for adult chronic inflammatory demyelinating polyneuropathy patients.
Based on the drug type, the market is segmented into corticosteroids, and immunoglobulin, among others.
By route of administration, the market is divided into oral and injectable.
Major distribution channels of the market include hospital pharmacies, retail pharmacies, and online pharmacies.
The market segmentation by countries includes the United States and Canada.
The key players in the market are CSL Behring, Grifols, S.A., Shire, Octapharma AG, Biogen Idec, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Sanofi, and Roche Holding AG.
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.